Cholesterol biosynthesis, peroxisomes and peroxisomal disorders: Mevalonate kinase is not only deficient in Zellweger syndrome but also in rhizomelic chondrodysplasia punctata

Journal of Inherited Metabolic Disease

Volumn 21, Issue 3, 1998, Pages 309-312

  Wanders, R J A ^a,b   Romeijn, G J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEVALONIC ACID; PHOSPHOTRANSFERASE;

CHOLESTEROL SYNTHESIS; CHONDRODYSPLASIA PUNCTATA; CLINICAL ARTICLE; CONFERENCE PAPER; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME ACTIVITY; ENZYME DEFICIENCY; HUMAN; PEROXISOME; ZELLWEGER SYNDROME;

CELLS, CULTURED; CHOLESTEROL; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC; FIBROBLASTS; HUMANS; MICROBODIES; PEROXISOMAL DISORDERS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); ZELLWEGER SYNDROME;

EID: 0031903775     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005353129761     Document Type: Conference Paper

References (13)

1. Biardi L, Sreedhar A, Zokaei A, et al (1994) Mevalonate kinase is predominantly localized in peroxisomes and is defective in patients with peroxisome deficient disorders. J Biol Chem 269: 1197-1205.
2. Braverman N, Steel G, Ohie C, et al (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nature Genetics 15: 369-375.
3. Erdmann R, Veenhuis M, Kunau WH (1997) Peroxisomes: organelles at the crossroads. Trends Cell Biol 7: 400-407.
4. Jansen GA, Mihalik SJ, Watkins PA, et al (1997) Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata. J Inher Metab Dis 20: 444-446.
5. Keller GA, Barton MC, Shapiro PJ, Singer SJ (1985) 3-Hydroxy-3-methylglutarylcoenzyme A reductase is present in peroxisomes in normal rat liver cells. Proc Natl Acad Sci USA 82: 770-774.
6. Keller GA, Pazirandeh M, Krisans SK (1986) 3-Hydroxy-3-methylglutaryl coenzyme A reductase localization in rat liver peroxisomes and microsomes of control and cholestyramine-treated animals: quantitative biochemical and immunoelectron microscopical analysis. J Cell Biol 103: 875-886.
7. Krisans SK (1996) Cell compartmentalization of cholesterol biosynthesis. Ann NY Acad Sci USA 804: 142-164.
8. Motley AM, Hettema EH, Hogenhout EM, et al (1997) Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nature Genetics 15: 377-380.
9. Purdue PE, Zhang JW, Skoneczny M, Lazarow PB (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nature Genetics 15: 381-384.
10. Schafer BL, Bishop RW, Kratuws VL, et al (1992) Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria. J Biol Chem 267: 13229-13238.
11. Stamellos KD, Shackelford JE, Tanaka RD, Krisans SK (1992) Mevalonate kinase is localized in peroxisomes. J Biol Chem 267: 5560-5568.
12. Wanders RJA, Romeijn GJ (1996) Cholesterol biosynthesis in Zellweger syndrome: normal activity of mevalonate kinase, mevalonate 5′-pyrophosphate decarboxylase and IPP isomerase in patients' fibroblasts but deficient mevalonate kinase activity in liver. J Inher Metab Dis 19: 193-196.
13. Wanders RJA, Schutgens RBH, Barth PG (1995) Peroxisomal disorders: a review. J Neuropathol Exp Neurol 54: 726-739.